Search results
Found 6229 matches for
Vaccitech, an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products, has secured £20 million in Series A financing.

Inflammatory and Musculoskeletal Disease
The Kennedy Trust for Rheumatology Research-funded OxKen programme will fully fund 4 Oxford University medical students each year from 2021-5 to undertake DPhils in the Medical Sciences Division in the fields of musculoskeletal disease, inflammation and immunology.
Computational Discovery
The DPhil in Computational Discovery is a multidisciplinary programme spanning projects in Advanced Molecular Simulations, Machine Learning and Quantum Computing to develop new tools and methodologies for life sciences discovery.
DPhil in Cancer Science
The DPhil in Cancer Science programme is unique and distinctive in offering integrated training across the following themes: Immunity, Infection & Inflammation; DNA Damage Response & Radiation Biology; Cancer Genetics & Epigenetics; and Cancer Big Data. It builds on Oxford’s outstanding research record in these areas, spanning both the University and Hospital Trust.